Loss of SHIP-1 expression impacts hematopoietic stem cells (HSC) and exacerbates altered myelopoiesis, which leads to the development of immunosuppressive MDSCs, Tregs, and pro-tumor M2-like TAM in the pancreatic TME, thus facilitating PC tumor progression (Figure 8). The gene discussed is INPP5D; the disease is neoplasm.